See how many news articles have been written about this stock in the past week. This graph compares this week's volume of news mentions of this stock to the weekly average for this stock.

News Score

Neutral

Sector
Average

Based on a formula that combines this week’s News Sentiment and Media Buzz

Combining News Sentiment and Media Buzz in a formula that provides one actionable score.

News Sentiment - Last 7 Days

VSTM This Week

Sector Weekly Average

VSTM

50% Bullish

50% Bearish

Sector Average:

61% Bullish

39% Bearish

See whether recent articles are Bullish or Bearish and how this compares to the sector average.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

Keywords mentioned in last week’s articles

The most common phrases from recent articles. Larger texts indicate more widely used phrases.

Bullish vs. Bearish News

2022-01-19VSTM

What is Wall Street's Target Price for Verastem Inc (VSTM) Stock Wednesday?Investors Observer

2022-01-11VSTM

Verastem Oncology Outlines Key 2022 Strategic Priorities and Upcoming Catalysts for Advancing VS-6766 as a Backbone of Therapy for RAS Pathway-Driven CancersYahoo Finance

2022-01-07VSTM

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635Yahoo Finance

2022-01-04VSTM

Verastem Oncology to Participate in Upcoming Investor ConferencesYahoo Finance

2021-12-30VSTM

Is Verastem Inc (VSTM) Stock at the Top of the Biotechnology Industry?Investors Observer

2021-12-23VSTM

The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For ReviewBenzinga

2021-11-23VSTM

Mirati , Verastem to Study Cancer Drugs for NSCLCYahoo Finance

2021-11-23VSTM

Verastem Inc (VSTM) Up 4.90% in Premarket TradingInvestors Observer

Healthcare Stocks that are Trending in the News

ZGNXZogenix

GMDAGamida Cell

KURAKura Oncology

ISRGIntuitive Surgical

VALNValneva

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Only $29.95/Month

Subscribe Now See Plans & Pricing